Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

This publication has 21 references indexed in Scilit:

• Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival: Results from the do tirofiban and reoprogive similar efficacy outcome trial (TARGET)
  Journal of the American College of Cardiology, 2003
• Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
  JAMA, 2002
• Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban)
  The American Journal of Cardiology, 2001
• Profile and prevalence of aspirin resistance in patients with cardiovascular disease
  The American Journal of Cardiology, 2001
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
  The Lancet, 2001
• Ticlopidine Pretreatment Before Coronary Stenting Is Associated With Sustained Decrease in Adverse Cardiac Events
  Circulation, 2001
• The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non–Q-wave myocardial infarctions
  Journal of the American College of Cardiology, 1998
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty
  Chest, 1998
• Development of aspirin resistance in persons with previous ischemic stroke.
  Stroke, 1994
• Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients
  Thrombosis Research, 1993